Clinical evaluation of extra-hematological comorbidity in myelodysplastic syndromes: "ready-to-wear" versus "made-to-measure" tools.
Articolo
Data di Pubblicazione:
2012
Abstract:
There is growing evidence to indicate that comorbidity has an unfavorable effect on life expectancy of patients with myelodysplastic syndromes (MDS), and significantly influences clinical decision making. These data strengthen the importance of not basing definition of the prognostic value of comorbidity in the clinical setting of MDS patients exclusively on the severity of the comorbid condition per se, but also taking MDS-specific features into account.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
MYELODYSPLASTIC SYNDROME; COMORBIDITY; PROGNOSIS
Elenco autori:
DELLA PORTA, MATTEO GIOVANNI; I., Ambaglio; M., Ubezio; E., Travaglino; C., Pascutto; Malcovati, Luca
Link alla scheda completa:
Pubblicato in: